Metraipolis › archive › dc_40d840285151

NAD+ reverses Alzheimer's neurological deficits via regulating differential alternative RNA splicing of EVA1C — Europe PMC PMID:41202143

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41202143
DOI
10.1126/sciadv.ady9811
License (as archived)
solo-consultazione
Archived
2026-11-08T18:00:12.407Z
SHA-256 of the archived text
7717dcc9a8669abb70a4d77673eed680f22c9315e5fd2b297a815e34f4ea8d79
Stable URL of this page
https://metraipolis.com/documento/dc_40d840285151

How to cite

NAD+ reverses Alzheimer's neurological deficits via regulating differential alternative RNA splicing of EVA1C — Europe PMC PMID:41202143 — Europe PMC (en), https://europepmc.org/article/MED/41202143 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_40d840285151 (Metraipolis archive dc_40d840285151, sha256 7717dcc9a8669abb70a4d77673eed680f22c9315e5fd2b297a815e34f4ea8d79)
BibTeX
@misc{dc40d840285151,
  title = {NAD+ reverses Alzheimer's neurological deficits via regulating differential alternative RNA splicing of EVA1C — Europe PMC PMID:41202143},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41202143},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_40d840285151; sha256 7717dcc9a8669abb70a4d77673eed680f22c9315e5fd2b297a815e34f4ea8d79},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41202143. Agents can read the archived copy with the MCP tool read_document.